Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis

Chemotherapy

Volumn 52, Issue 3, 2006, Pages 130-136

  Monzote, Lianet ^a   Montalvo, Ana M ^a   Almanonni, Salah ^c   Scull, Ramon ^b   Miranda, Migdalia ^b   Abreu, Juan ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b UNIVERSITY OF HAVANA   (Cuba)

^c Infectious Diseases Area   (Libyan Arab Jamahiriya)

Author keywords

Amastigote; BALB c mice; Chenopodium ambrosioides; Leishmania amazonensis; Macrophage; Promastigote

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; CHENOPODIUM AMBROSIOIDES EXTRACT; ESSENTIAL OIL; MIGLYOL;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CHENOPODIUM AMBROSIOIDES; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; FEMALE; GAS CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA; LEISHMANIASIS; MASS SPECTROMETRY; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMASTIGOTE; TRADITIONAL MEDICINE;

ANIMALS; CHENOPODIUM AMBROSIOIDES; CUBA; FEMALE; INJECTIONS, INTRAPERITONEAL; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED BALB C; OILS, VOLATILE; PLANT OILS;

EID: 33646803835     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092858     Document Type: Article

References (24)

1. Desjeux P: The increase in risk factors for leishmaniasis worldwide. R Trans Soc Trop Med Hyg 2001;95:239-243.
2. Delorenzi JC, Attias M, Gattass CR, Andrade M, Rezende C, Da Cunha A, Henriques A, Bou-Habib DC, Saraiva EMB: Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrob Agents Chemother 2001;45:1349-1354.
3. Bolaert M, Le Ray D, Van der Stuyft P: How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis. Trop Med Int Health 2002;7:955-959.
4. Plock A, Sokolowska-Köhler W, Presber W: Application of flow cytometry and microscopical methods to characterise the effect of herbal drugs on Leishmania spp. Exp Parasitol 2001;97:141-153.
5. Caio E, Lima D, Kaplan MAC, Nazareth M, Rossi-Bergmann B: Selective effect of 2′,6′-dihydroxy-4′-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob Agents Chemother 1999;43:1234-1241.
6. Berman J, Dietze R: Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion. Chemotherapy 1999;45:54-66.
7. Ahmed AA: Highly oxygenated monoterpenes from Chenopodium ambrosioides. J Nat Prod 2000;63:989-991.
8. Kiuchi F, Itano Y, Uchiyama N, Honda G, Tsubouchi A, Nakajima-Shimada J, Aoki T: Monoterpene hydroperoxides with trypanocidal activity from Chenopodium ambrosioides. J Nat Prod 2002;65:509-512.
9. Monzote L, Sariego I, Montalvo AM, Garrido N, Scull R, Abreu J: Propiedades antiprotozoarias de aceites esenciales extraídos de plantas cubanas. Rev Cubana Med Trop 2004;56:230-233.
10. MacDonald D, vanCrey K, Harrison P, Rangachari PK, Rosenfeld J, Warren C: Ascaridole-less infusions of Chenopodium ambrosioides contain a nematocide(s) that is (are) not toxic to mammalian smooth muscle. J Ethnopharmacol 2004;92:215-221.
11. Franca F, Lago EL, Marsden PD: Plant used in the treatment of leishmanial ulcers due to Leishmania (Vianna) braziliensis in an endemic area of Bahia, Brazil. Rev Soc Bras Med Trop l996;29:229-232.
12. Norma Ramal: NRSP 309: Medicamentos de origen vegetal. Droga cruda. Métodos de ensayos. Havana, 1992.
13. Bodley AL, McGarry MW, Shapiro TA: Drug cytotoxicity assay for African trypanosomes and Leishmania species. J Infect Dis 1995;172:1157-1159.
14. Sladowski D, Steer SJ, Clothier RH, Balls M: An improve MTT assay. J Immunol Methods 1993;157:203-207.
15. Croft SL, Neal RA, Thornton EA, Herrmann DBJ: Antileishmanial activity of the ether phospholipid ilmofosine. R Trans Soc Trop Med Hyg l993;87:217-219.
16. Da Silva SAG, Costa SS, Mendoça SCF, Silva EM, Moraes VLG, Rossi-Bergmann B: Therapeutic effect of oral Kalanchoe pinnata leaf extract in murine leishmaniasis. Acta Trop 1995;60:201-210.
17. Rodríguez N, Bailey BN, Martin MB, Oldfield E, Urbina J: Radical cure of experimental cutaneous leishmaniasis by the bisphosphanate pamidronate. J Infect Dis 2002;186:138-140.
18. Buffet PA, Sulahian A, Garin YJF, Nassar N, Derouin F: Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrob Agents Chemother 1995;39:2167-2168.
19. Chan-Bacab MJ, Balanza E, Deharo E, Muñoz V, García RD, Peña-Rodríguez LM: Variation of leishmanicidal activity in tour populations of Urechites andrieuxii. J Ethnopharmacol 2003;86:243-247.
20. Fournet A, Ferreira ME, Rojas de Arias A, Torres de Ortiz S, Fuentes S, Nakayama H: In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of New World cutaneous leishmaniasis caused by Leishmania amazonensis. Antimicrob Agents Chemother 1996;40:2447-2451.
21. Abreu-Silva AL, Calabrese KS, Tedesco RC, Mortara RA, Gonçalvez SC: Central nervous system involvement in experimental infection with Leishmania amazonensis. Am J Trop Med Hyg 2003;68:661-665.
22. Ji J, Sun J, Qi H, Soong L: Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg 2002;66:338-345.
23. Barão SC, Giorgio S: Efficacy of 8-bromoguanosine against murine cutaneous leishmaniasis induced with Leishmania amazonensis. Chemotherapy 2003;49:159-162.
24. Al-Abdely HM, Graybill JR, Loebenberg D, Melby PC: Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniasis. Antimicrob Agents Chemother 1999;43:2910-2914.